Inhibition of Epidermal Growth Factor/HER2 Receptor Signaling Using ZD1839

Reviewer: Thomas Dilling, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 18 de mayo del 2002

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

ASCO Issues Guidelines for Advanced HER2+ Breast Cancer

May 8, 2014

Recommendations provided for management of advanced disease without, with brain mets

Dual Inhibition of HER2 Beats Single Agent in Breast Cancer

Jan 18, 2012

For HER2-positive breast cancer, inhibition with lapatinib and trastuzumab superior to single agent

Alternate Chromosome 17 Genes Detect True HER2 Status

Sep 29, 2011

Three alternative chromosome 17 genes determine true HER2 status in breast cancer with polysomy 17